Newly developed evaluation for intestinal permeability using Caenorhabditis elegans: protective effects of agaro-oligosaccharides on intestinal permeability
Journal of Clinical Biochemistry and Nutrition · 2025 · 77 (2) · 113-119
DOI: 10.3164/jcbn.24-149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Biochemistry and Nutrition, 2025. Verfasst von Natsumi Desaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Ishikawa Prefectural University, Nonoichi, Ishikawa 921-8836, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food Science, Ishikawa Prefectural University, Nonoichi, Ishikawa 921-8836, Japan.
- Department of Human Immunology and Nutrition Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
Zitieren
APA
Desaka, N., Naito, Y., & Higashimura, Y. (2025). Newly developed evaluation for intestinal permeability using Caenorhabditis elegans: protective effects of agaro-oligosaccharides on intestinal permeability. Journal of Clinical Biochemistry and Nutrition, 77(2), 113-119. https://doi.org/10.3164/jcbn.24-149
Vancouver
Desaka N, Naito Y, Higashimura Y. Newly developed evaluation for intestinal permeability using Caenorhabditis elegans: protective effects of agaro-oligosaccharides on intestinal permeability. Journal of Clinical Biochemistry and Nutrition. 2025;77(2):113-119. doi:10.3164/jcbn.24-149
BibTeX
@article{Desaka2025,
author = {Desaka, Natsumi and Naito, Yuji and Higashimura, Yasuki},
title = {Newly developed evaluation for intestinal permeability using Caenorhabditis elegans: protective effects of agaro-oligosaccharides on intestinal permeability},
journal = {Journal of Clinical Biochemistry and Nutrition},
year = {2025},
volume = {77},
number = {2},
pages = {113--119},
doi = {10.3164/jcbn.24-149}
}
EUVIMED